Search

Search Constraints

You searched for: Author/Creator Smolen, Josef

Search Results

1. 04.05 The metabolic checkpoint kinase mtor regulates the rheumatoid mesenchymal tissue response to inflammation. (1st March 2017)

2. 074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis. (12th April 2019)

3. 08.28 The prognostic value of iga autoantibodies (rheumatoid factor and acpa) for prediction of the therapeutic response to anti-tnf therapy in patients with rheumatoid arthritis. (1st March 2017)

4. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Issue 1 (24th November 2021)

5. 245 Remission/low disease activity is an achievable treatment target in psoriatic arthritis (PsA): results from a routine care European cohort of PsA patients treated with ustekinumab or TNF inhibitors. (12th April 2019)

6. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Issue 3 (24th November 2016)

10. A8.7 Functional Impairment in an Animal Model for Rheumatoid Arthritis Assessed as Changes in Gait is Due to Joint Destruction But Not Synovial Inflammation Per Se. (25th February 2013)